
McKesson, Cardinal Health and AmerisourceBergen were accused of ignoring shipments of painkillers being diverted to illegal channels, while J&J allegedly downplayed the the risk of addiction in its marketing materials for opioids, which the firm stopped making in 2020. All companies have denied the allegations.
Recent Comments